Cost-effectiveness and cost-utility of the adherence improving self-management strategy in human immunodeficiency virus care: a trial-based economic evaluation
Abstract:
Background Several promising human immunodeficiency virus (HIV) treatment adherence interventions have been identified, but data about their cost-effectiveness are lacking. This study examines the trial-based cost-effectiveness and cost-utility of the proven-effective Adherence Improving Self-Management Strategy (AIMS), from a societal perspective, with a 15-month time horizon. Methods Treatment-naive and treatment-experienced patients at risk for viral rebound were randomized to treatment as usual (TAU) or AIMS in a multicenter randomized controlled trial in the Netherlands. AIMS is a nurse-led, 1-on-1 self-management intervention incorporating feedback from electronic medication monitors, delivered during routine clinical visits. Main outcomes were costs per reduction in log10 viral load, treatment failure (2 consecutive detectable viral loads), and quality-adjusted …
Año de publicación:
2019
Keywords:
Fuente:

Tipo de documento:
Other
Estado:
Acceso abierto
Áreas de conocimiento:
- Salud Pública
Áreas temáticas de Dewey:
- Medicina forense; incidencia de enfermedades
- Problemas sociales y servicios a grupos

Objetivos de Desarrollo Sostenible:
- ODS 3: Salud y bienestar
- ODS 10: Reducción de las desigualdades
- ODS 17: Alianzas para lograr los objetivos
